Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

LUMICKS

Financiado

Cerrado

z Movi cell screening and sorting platform

Cell immunotherapy is a breakthrough treatment that uses immune cells to directly attack tumours. It is considered the most exciting development in cancer treatment in years. When it works, patients with life-threatening cancers l... ver más

30/09/2022

LUMICKS CA BV

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

LUMICKS CA BV No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 4 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-09-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

4 Participantes

LUMICKS CA BV

1.28M€ | Lider

INSTITUTO TECNOLOGICO Y DE E...

252.15K€ | Participante

MM CICOM TELECOMUNICACIONES

292.94K€ | Participante

LUMICKS

728.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

3DPD PhD position in commercial environment cancer immunotherapy... 135K€ Cerrado

OncoSeq OncoSeq an innovative single cell system for immunomonitori... 150K€ Cerrado

RARITY RAtional design of canceR ImmunoTherapY one size does not f... 1M€ Cerrado

DECOD-Ag Revolutionary Platform to Decipher Immunogenicity of Tumour... 3M€ Cerrado

PID2020-118529RB-I00 EXPLOTANDO LOS DETERMINANTES MOLECULARES DE LA RESPUESTA T A... 218K€ Cerrado

DevoSignGammaDelta Tracking T cell development and TCR proximal signalling 161K€ Cerrado

Duración del proyecto: 24 meses Fecha Inicio: 2020-09-16
Fecha Fin: 2022-09-30

Líder del proyecto

LUMICKS CA BV No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cell immunotherapy is a breakthrough treatment that uses immune cells to directly attack tumours. It is considered the most exciting development in cancer treatment in years. When it works, patients with life-threatening cancers live far longer or may even be cured. But so far, immunotherapy only works for few types of cancer and few patients, and finding the most effective immune cells is still an immense challenge. LUMICKS is developing z-Movi, the first high-throughput platform that screens and sorts immune cells based on their functionality using non-invasive techniques. z-Movi is a unique and powerful solution that now allows researchers to look at thousands of immune cells and find the right ones within a couple of minutes – a process that would take months with standard technologies. Therefore, z-Movi is the perfect R&D tool to help and speed up the process of bringing new immunotherapy treatments to market. z-Movi is expected to disrupt the immunotherapy market, which is mostly driven by innovation and is expected to reach €100B by 2021. LUMICKS started by teaming-up with immunotherapy leaders such as the Dutch Cancer Institute and Institut Pasteur to develop z-Movi. The first developed z-Movi was already introduced to early adopters. After completing optimisation, a new generation z-Movi will target the immunology research institutes, biotech and pharma markets. Users from those segments have already demonstrated concrete interest in our solution, or are in the process of acquisition. The incremental z-Movi revenue stream from this EIC Accelerator project will be around €20M by 2022 and the net profit margin will double. LUMICKS’ post-EIC ultimate goal is to go beyond the

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores